Back to AMLX
Janus Henderson Group Ltd. → AMLX
Janus Henderson Group Ltd. AMLX Position History
Amylyx Pharmaceuticals, Inc. • Healthcare
Quarters held
9
Latest value
$153.5M
Q3 2026
Peak value
$153.5M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $467K |
| Q4 2025 | $53.5M |
| Q1 2026 | $68.7M |
| Q1 2026 | $536K |
| Q1 2026 | $536K |
| Q1 2026 | $68.7M |
| Q3 2026 | $169K |
| Q3 2026 | $3.3M |
| Q3 2026 | $153.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $153.5M | 5.28M | — | — |
| Q3 2026 | $3.3M | 114.4K | — | — |
| Q3 2026 | $169K | 5.8K | — | — |
| Q1 2026 | $68.7M | 4.95M | — | — |
| Q1 2026 | $536K | 38.6K | — | — |
| Q1 2026 | $536K | 38.6K | — | — |
| Q1 2026 | $68.7M | 4.95M | — | — |
| Q4 2025 | $53.5M | 4.43M | — | — |
| Q4 2025 | $467K | 38.6K | — | — |
Other funds holding AMLX
$460.9M
$307.7M
$261.7M
$201.3M
$174.7M
$153.4M